🇺🇸 GnRH agonist in United States

7 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Cervical Incompetence — 1 report (14.29%)
  2. Cervix Cerclage Procedure — 1 report (14.29%)
  3. Metrorrhagia — 1 report (14.29%)
  4. Neuroendocrine Carcinoma Metastatic — 1 report (14.29%)
  5. Normal Newborn — 1 report (14.29%)
  6. Shortened Cervix — 1 report (14.29%)
  7. Uterine Contractions During Pregnancy — 1 report (14.29%)

Source database →

GnRH agonist in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is GnRH agonist approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for GnRH agonist in United States?

Cairo University is the originator. The local marketing authorisation holder may differ — check the official source linked above.